New Generic Drug House Private Limited - Company Profile

It is a pharma private limited company based in Valsad, Gujarat, India, established in 1983.
1983 Valsad, Gujarat, India Active
Last Updated:
Access Report
About New Generic Drug House Private Limited

New Generic Drug House Private Limited, a active private limited company, was established on 05 May 1983 in Valsad, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230GJ1983PTC006156. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹9.66 M.

It upholds a active non-compliant status. Its leadership includes Jasumati Pramodrai Vyas (Additional Director), Dhirajlal Mepabhai Patel (Director). Past directors included Mahesh Labhubhai Trivedi, Dhirajlal Mepabhai Patel, Atul Pramodrai Vyas. It holds no open charges and ₹6.85 Cr settled loans. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at 211 & 213, Gidc Industrial Estate, Village- Sarigam, Valsad, Gujarat, 396155.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230GJ1983PTC006156

  • Registration Number

    006156

  • Incorporation Date

    05 May 1983

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹9.66 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 9.66 M
  • Company Age 42 Year, 9 Months
  • Last Filing with ROC 31 Mar 2018
  • Satisfied Charges ₹ 6.85 Cr
  • Revenue Growth **** -50.00%
  • Profit Growth **** 97.04%
  • Ebitda **** 74.38%
  • Net Worth -0.00%
  • Total Assets **** 0.12%
Company report

New Generic Drug House Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into New Generic Drug House Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at New Generic Drug House Private Limited?
Current Directors
Name Designation Appointment Date Status
Jasumati Pramodrai Vyas Additional Director 26 Feb 2019 Current
Dhirajlal Mepabhai Patel Director 09 Jun 2010 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 Oct 2010 Past
Pramod Abcsdd Additional Director 30 Sep 2010 Past
Pramod Abcsdd Managing Director 26 Feb 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of New Generic Drug House.

New Generic Drug House Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 50% decrease. The company also saw a substantial improvement in profitability, with a 97.04% increase in profit. The company's net worth witnessed no change by increase of -0%.

New Generic Drug House revenue growth over time
New Generic Drug House profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -50.00%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 0.12%
*******
*******
*******
*******
Profit or Loss
*******
 97.04%
*******
*******
*******
*******
Net Worth
*******
 -0.00%
*******
*******
*******
*******
EBITDA
*******
 74.38%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of New Generic Drug House?

In 2018, New Generic Drug House had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹68,500,000.00

Charges Breakdown by Lending Institutions
  • Jankalyan Sehkari Bank Ltd : 6.10 Cr
  • Janakalyan Sahakari Bank Limited : 0.50 Cr
  • Jankalyan Sahakari Bank Limited : 0.25 Cr
Latest Charge Details
Date Lender Amount Status
29 Mar 2004 Jankalyan Sehkari Bank Ltd ₹3.50 M Satisfied
23 Jul 2003 Jankalyan Sehkari Bank Ltd ₹7.50 M Satisfied
16 Jan 2002 Jankalyan Sehkari Bank Ltd ₹2.00 Cr Satisfied
28 Jan 2000 Jankalyan Sehkari Bank Ltd ₹1.50 Cr Satisfied
01 Sep 1998 Jankalyan Sahakari Bank Limited ₹2.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at New Generic Drug House?

Unlock and access historical data on people associated with New Generic Drug House, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of New Generic Drug House, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Generic Drug House's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on New Generic Drug House
Recent Activity within the Organization
  • Director Appointment

    Progress on Jasumati Pramodrai Vyas was appointed as a Additional Director was appointed as a Additional Director on 26 Feb 2019 & has been associated with this company since 7 years . was documented.

  • Annual General Meeting

    Progress on New Generic Drug House Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was documented.

  • Balance Sheet

    New Generic Drug House Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Ahmedabad. was recorded as a recent event.

  • Charges

    A charge registered on 29 Mar 2004 via Charge ID 90110714 with Jankalyan Sehkari Bank Ltd was fully satisfied on 09 Sep 2010. was recorded as a recent event.

  • Charges

    A charge registered on 23 Jul 2003 via Charge ID 90110594 with Jankalyan Sehkari Bank Ltd was fully satisfied on 09 Sep 2010. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 16 Jan 2002 via Charge ID 90110393 with Jankalyan Sehkari Bank Ltd was fully satisfied on 09 Sep 2010. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of New Generic Drug House Private Limited?

The CIN of New Generic Drug House Private Limited is U24230GJ1983PTC006156.

Where is New Generic Drug House Private Limited headquartered?

New Generic Drug House Private Limited is headquartered at 211 & 213, Gidc Industrial Estate, Village- Sarigam, Valsad, Gujarat, 396155.

When was New Generic Drug House Private Limited incorporated?

New Generic Drug House Private Limited was incorporated on 05 May 1983.

Who are the current directors of New Generic Drug House Private Limited?

The current directors of New Generic Drug House Private Limited are

What is the primary industry of New Generic Drug House Private Limited?

The primary industry of New Generic Drug House Private Limited is Pharma.

Is New Generic Drug House Private Limited a listed company?

New Generic Drug House Private Limited is unlisted.

What is the capital structure of New Generic Drug House Private Limited?

The authorized capital of New Generic Drug House Private Limited is ₹2.00 Cr, and the paid-up capital is ₹9.66 M.

What is the compliance status of New Generic Drug House Private Limited?

The compliance status of New Generic Drug House Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available